Clinical Trial Update: Efficacy of Apraclonidine Eye Drops in the Treatment of Ptosis Secondary to Myasthenia Gravis [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating the efficacy of apraclonidine eye drops for ptosis in myasthenia gravis, completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Myasthenia Gravis
• Ocular Myasthenia Gravis

Drugs mentioned

• apraclonidine eye drops (apraclonidine)

Snippet

Sponsor: American University of Beirut Medical Center | Conditions: Myasthenia Gravis, Ocular Myasthenia Gravis | Phase 2 | Status: COMPLETED